Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
Clinical trial NCT00026494 · COMPLETED
Trial details
- NCT number
- NCT00026494
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Primary completion
- 2008-04-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.